American CryoStem Corp (CRYO):企業の財務・戦略的SWOT分析

◆英語タイトル:American CryoStem Corp (CRYO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14527
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
American CryoStem Corp (American CryoStem), formerly Advanced Wound Technologies-MidAtlantic LLC is a manufacturer, developer, and marketer of life-enhancing and stem cell technologies. The company offers products such as adipose derived stem cells, tissue collection and transportation products, and cell media products. It offers cell media products that provides therapeutic interventions used in repair and regeneration of bone tissue, cardiac tissue, cartilage, and even nervous tissue. American CryoStem offers customized contract manufacturing services to researchers, institutions, CROs and other independent biotech companies in support of clinical and basic stem cell research and development. The company’s products are used in burn and wound healing, personalized health care, joint repair, and disease treatment and management applications. American CryoStem is headquartered in Eatontown, New Jersey, the US.

American CryoStem Corp Key Recent Developments

Jul 12,2018: American CryoStem announces launch of ATGRAFT in China
Jun 19,2018: American CryoStem to develop standardized tissue scoring system
Mar 27,2018: Cryo Announces Notice of Allowance of Claims for Its Core Patent
Jan 16,2018: American Cryostem Announces 2017 Year End Update
Jan 08,2018: American CryoStem Statement on the Receipt of a Warning Letter from FDA

This comprehensive SWOT profile of American CryoStem Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of American CryoStem Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

American CryoStem Corp – Key Information
American CryoStem Corp – Overview
American CryoStem Corp – Key Employees
American CryoStem Corp – Key Employee Biographies
American CryoStem Corp – Key Operational Heads
American CryoStem Corp – Major Products and Services
American CryoStem Corp – History
American CryoStem Corp – Company Statement
American CryoStem Corp – Locations And Subsidiaries
American CryoStem Corp – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

American CryoStem Corp – Business Description
American CryoStem Corp – Corporate Strategy
American CryoStem Corp – SWOT Analysis
SWOT Analysis – Overview
American CryoStem Corp – Strengths
American CryoStem Corp – Weaknesses
American CryoStem Corp – Opportunities
American CryoStem Corp – Threats
American CryoStem Corp – Key Competitors

Section 3 – Company Financial Performance Charts

American CryoStem Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

American CryoStem Corp, Key Information
American CryoStem Corp, Key Ratios
American CryoStem Corp, Share Data
American CryoStem Corp, Major Products and Services
American CryoStem Corp, History
American CryoStem Corp, Key Employees
American CryoStem Corp, Key Employee Biographies
American CryoStem Corp, Key Operational Heads
American CryoStem Corp, Other Locations
American CryoStem Corp, Subsidiaries
American CryoStem Corp, Key Manufacturing facilities
American CryoStem Corp, Key Competitors
American CryoStem Corp, SWOT Analysis
American CryoStem Corp, Ratios based on current share price
American CryoStem Corp, Annual Ratios
American CryoStem Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

American CryoStem Corp, Performance Chart
American CryoStem Corp, Ratio Charts

★海外企業調査レポート[American CryoStem Corp (CRYO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Punj Lloyd Ltd (PUNJLLOYD):企業の財務・戦略的SWOT分析
    Punj Lloyd Ltd (PUNJLLOYD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • VentriPoint Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary VentriPoint Diagnostics Ltd (Ventripoint) is a medical device company that manufactures and distributes diagnostic tools and monitoring devices for patients with heart diseases. The company provides ventripoint diagnostic system, which is a cardiovascular monitoring and measurement device. I …
  • NHPC Ltd (NHPC):電力:M&Aディール及び事業提携情報
    Summary NHPC Ltd (NHPC), a Government of India Enterprise, is an energy utility. It plans, promotes and organizes the development of hydro power plants. The company generates electricity using hydro, wind and solar sources. NHPC’s offerings cover the development operations of conventional and non-co …
  • Tenaga Nasional Berhad:企業の戦略・SWOT・財務情報
    Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Gazprom (GAZP):電力:M&Aディール及び事業提携情報
    Summary Gazprom is an integrated global oil and gas company. It carries out the exploration, production, transportation, storage, processing and marketing of natural gas, gas condensate and crude oil. The company also sells gas as a vehicle fuel and participates in the generation and marketing of he …
  • Little Caesar Enterprises Inc:企業の戦略・SWOT・財務分析
    Little Caesar Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Little Caesar Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Largan Precision Co Ltd (3008):企業の財務・戦略的SWOT分析
    Largan Precision Co Ltd (3008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ResMed Inc. (RMD):医療機器:M&Aディール及び事業提携情報
    Summary ResMed Inc. (ResMed) develops, manufactures and distributes medical equipment for the diagnosis, treatment and management respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea and chronic obstructive pulmonary disease (COPD). Its major products include air flow generato …
  • Geron Corp (GERN):製薬・医療:M&Aディール及び事業提携情報
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …
  • Dubai Islamic Bank P.J.S.C.:戦略・SWOT・企業財務分析
    Dubai Islamic Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Dubai Islamic Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • PPG Industries Inc (PPG):企業の財務・戦略的SWOT分析
    PPG Industries Inc (PPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dover Corp (DOV):企業の財務・戦略的SWOT分析
    Dover Corp (DOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Metro AG:戦略・SWOT・企業財務分析
    Metro AG - Strategy, SWOT and Corporate Finance Report Summary Metro AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • WNS (Holdings) Limited:企業の戦略・SWOT・財務情報
    WNS (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary WNS (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Kering SA:企業のM&A・事業提携・投資動向
    Kering SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kering SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Zehnder Group AG (ZEHN):企業の財務・戦略的SWOT分析
    Zehnder Group AG (ZEHN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Oncternal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oncternal Therapeutics Inc (Oncternal) is a clinical-stage oncology company that develops therapies for rare and common cancers. The company’s pipeline compounds include cirmtuzumab and TK216. Its compounds are primarily focused on exciting targets which are uniquely expressed within cancer …
  • Lam Research Corporation:企業の戦略・SWOT・財務分析
    Lam Research Corporation - Strategy, SWOT and Corporate Finance Report Summary Lam Research Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Petrofac Ltd (PFC):企業の財務・戦略的SWOT分析
    Petrofac Ltd (PFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • OAO Tatneft:企業の戦略・SWOT・財務情報
    OAO Tatneft - Strategy, SWOT and Corporate Finance Report Summary OAO Tatneft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆